Mentice Appoints Thanos Karras New VP of Global Marketing
Mentice, an endovascular performance company focused on improving patient outcomes and driving operational excellence in the cath-lab, today announced the appointment of Thanos Karras, a senior healthcare industry executive, as Vice President of Global Marketing. Mr. Karras will be responsible for leading the corporate go-to-market strategy, exploring new business models, and overseeing the development of the Mentice brand.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190305005081/en/
Mentice Appoints Thanos Karras New VP of Global Marketing (Photo: Business Wire)
“We are delighted to welcome Thanos as Vice President of Global Marketing at Mentice,” said Mentice CEO Goran Malmberg. “Thanos is a talented executive with a truly global perspective and a proven track record of driving innovation and growth in the healthcare industry. He has the leadership credentials and experience to help advance the company’s position as the world leader in advanced simulation technologies and performance solutions designed to improve outcomes and optimize operations in the interventional lab.”
“I am honored and excited to join Mentice--a great company focused on addressing operational and clinical challenges that ultimately impact delivery of care,” said Thanos. “I believe the company’s 20-year history of innovation, unparalleled platform, and unmatched intellectual capital have tremendous potential to drive interventional lab improvements to health systems worldwide. I look forward to working with the Mentice team to continue and grow the company as the global healthcare leader.”
Thanos brings exceptional healthcare industry experience and a strong track record to Mentice. Over the last 20 years, he has held global healthcare IT and medical device leadership positions in marketing, product management, business development, and business management. He has helped grow and nurture businesses of all sizes: from early stage startups to global corporations such as GE and Siemens.
Thanos earned an M.B.A. from the Kellogg School of Management and has a Master of Engineering in Computer Science from the University Florida. He is a member of Chicago Innovation Mentors (CIM) mentoring early-stage startups.
Mentice is the world leader in virtual reality‐based interventional medical simulation solutions. Our solutions help healthcare professionals with skills acquisition, continuous development and pre-procedural planning—leading to improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical industry. Neurovascular, cardiovascular and peripheral interventions are just some of the areas covered by our systems. For more information about Mentice, visit www.mentice.com .
For more information:
Stacy Hammar, Marketing Communication Manager, EMEA
+46 (0) 31 339 94 94
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 13:27:00 CET | Pressemelding
Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel
Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 13:17:00 CET | Pressemelding
BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President
Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 13:09:00 CET | Pressemelding
Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi
Workiva Wins DevOps Excellence Award in London21.3.2019 13:03:00 CET | Pressemelding
Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting
Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate21.3.2019 11:30:00 CET | Pressemelding
Teleflex Incorporated (NYSE:TFX) today announced that multiple studies were presented at the 2019 European Association of Urology (EAU) meeting in Barcelona, Spain, highlighting the effectiveness of the UroLift® System, a minimally invasive treatment, usually performed in-office that provides rapid relief and recovery from the symptoms of benign prostatic hyperplasia (BPH).1,2 BPH, also known as enlarged prostate, is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life.3 BPH affects over 40 million men in the United States alone.4 If left untreated, the condition can worsen over time and cause permanent bladder damage.5 A presentation entitled Pulling The Foley: Can the Prostatic Urethral Lift be used in men with catheter-dependent urinary retention? was presented by Thomas Mueller, M.D., urologist of New Jersey Urology (Voorhees, N.J.). The study highlighted real-world retrospective d
Smiths Detection Now Has Two Scanners with ECAC Standard 3.1 Approval21.3.2019 11:23:00 CET | Pressemelding
Smiths Detection has achieved ECAC Standard 3.1 approval for its CTX 9800 DSi™ 0.5 m/s hold baggage explosives detection system. This is the second Smiths Detection scanner to achieve 3.1 approval - the highest defined hold baggage screening standard in the EU. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005332/en/ Smiths Detection Now Has Two Scanners with ECAC Standard 3.1 Approval (Photo: Business Wire) Any previously installed CTX 9800 DSi systems with Standard 3 approval can be upgraded on site to include Standard 3.1. The detection algorithms for the two standards may be selected on a bag-by-bag basis depending on the destination and associated risk level. This risk-based screening approach offers additional flexibility and productivity whilst maintaining the highest level of security. “We are seeing more customers stipulating a preference for equipment with Standard 3.1 approval in their tenders,” explained M